1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. 5-HT Receptor
  4. 5-HT2 Receptor Isoform
  5. 5-HT2 Receptor Agonist

5-HT2 Receptor Agonist

5-HT2 Receptor Agonists (41):

Cat. No. Product Name Effect Purity
  • HY-136109
    SEP-363856 hydrochloride
    Agonist 99.57%
    SEP-363856 hydrochloride (SEP-856 hydrochloride), an orally active and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects.
  • HY-19545A
    SCH-23390 hydrochloride
    Agonist 99.91%
    SCH-23390 hydrochloride (R-(+)-SCH-23390 hydrochloride) is a potent and selective dopamine D1-like receptor antagonist with Kis of 0.2 nM and 0.3 nM for the D1 and D5 receptor, respectively.
  • HY-103138
    (Rac)-WAY-161503 hydrochloride
    Agonist
    (Rac)-WAY-161503 hydrochloride is a potent, selective, high affinity 5-HT2C receptor agonist with a Ki of 4 nM and an EC50 of 12 nM.
  • HY-14546
    Aripiprazole
    Agonist 99.93%
    Aripiprazole (OPC-14597), an atypical antipsychotic, is a potent and high-affinity dopamine D2 receptor partial agonist.
  • HY-14544
    Quetiapine
    Agonist 99.88%
    Quetiapine (ICI204636) is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor.
  • HY-101369
    BW-723C86
    Agonist 99.80%
    BW-723C86 is a potent and a selective 5-HT2B receptor agonist.
  • HY-111200
    Vabicaserin hydrochloride
    Agonist 99.92%
    Vabicaserin hydrochloride is a 5-hydroxytryptamine 2C (5-HT2C) receptor-selective agonist with an EC50 of 8 nM.
  • HY-14153A
    Tegaserod maleate
    Agonist 99.93%
    Tegaserod maleate (SDZ-HTF-919) is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist.
  • HY-15543A
    CP-809101 hydrochloride
    Agonist 99.83%
    CP-809101 hydrochloride is a potent and highly selective 5-HT2C receptor agonist, with pEC50s of 9.96, 7.19 and 6.81 M for human 5HT2C, 5HT2B and 5HT2A receptor.
  • HY-B0031
    Quetiapine hemifumarate
    Agonist 99.94%
    Quetiapine hemifumarate is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor.
  • HY-13788
    LY 344864
    Agonist 98.93%
    LY 344864 is a selective, orally active 5-HT1F receptor agonist with a Ki of 6 nM.
  • HY-100820
    Sarizotan
    Agonist 98.74%
    Sarizotan (EMD 128130) is an orally active serotonin 5-HT1A receptor and dopamine receptor agonist.
  • HY-13221
    BRL 54443
    Agonist 99.89%
    BRL 54443 is a potent 5-HT1E/1F receptor agonist (Ki values are 1.1 nM and 0.7 nM respectively); displays > 30-fold selectivity over other 5-HT and dopamine receptors.
  • HY-113008A
    cis-Urocanic acid
    Agonist 99.92%
    cis-Urocanic acid is a 5-HT2A receptor agonist.
  • HY-133024
    Flumexadol
    Agonist 98.87%
    Flumexadol is a selective and affinity 5-HT2C receptor agonist with a Ki of 25 nM for the (+)-enantiomer of Flumexadol, and is 40-fold selective over the 5-HT2A receptor.
  • HY-103110
    ST1936
    Agonist 99.70%
    ST1936 is a selective, nanomolar affinity 5-HT6 receptor agonist with Ki values of 13 nM, 168 nM and 245 nM for human 5-HT6, 5-HT7 and 5-HT2B receptors, respectively.
  • HY-15394
    (Rac)-Rotigotine hydrochloride
    Agonist 98.66%
    (Rac)-Rotigotine hydrochloride is a racemate of Rotigotine.
  • HY-123838
    Ro60-0175
    Agonist 99.98%
    Ro60-0175 is a potent and selective agonist of 5-HT2C receptor.
  • HY-16729A
    Relenopride hydrochloride
    Agonist 99.13%
    Relenopride (YKP10811) hydrochloride is a specific and selective 5-HT4 receptor agonist (Ki=4.96 nM).
  • HY-136109A
    SEP-363856
    Agonist
    SEP-363856 (SEP-856), an orally active and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects.